Author

J. Quinones

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Organism:Arabidopsis· 1 Research Focus:cell type annotation· 1 Assay:multiome· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

A. Carfi· 2 shared A. Choi· 2 shared A. Woods· 2 shared C. Henry· 2 shared D. K. Edwards· 2 shared D. Lee· 2 shared K. Wu· 2 shared L. Ma· 2 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Carfi

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Development of SARS-CoV-2 mRNA vaccines encoding spike N-terminal and receptor binding domains

G. Stewart-Jones, S. M. Elbashir, K. Wu, D. Lee, I. Renzi, B. Ying, M. Koch, C. E. Sein, A. Choi, B. Whitener, D. Garcia-Dominguez, C. Henry, A. Woods, L. Ma, D. Montes Berrueta, , A. Carfi

The paper develops and evaluates an mRNA vaccine, mRNA-1283, encoding SARS-CoV-2 spike N-terminal and receptor-binding domains, showing improved immunogenicity and protection against multiple variants in mice.

bioRxiv · Oct 7, 2022 · PreprintImmunology

Comparative genomics of Acinetobacter baumannii and therapeutic bacteriophages from a patient undergoing phage therapy

M. Liu, A. C. Hernandez-Morales, J. Clark, T. T. Le, B. Biswas, K. A. Bishop-Lilly, M. S. Henry, J. Quinones, T. Hamilton, R. Schooley, S. Salka, R. F. Young, J. J. Gill

This study reports the genomes of phages and A. baumannii isolates from a phage therapy case, showing rapid resistance development and identifying capsule locus mutations linked to phage insensitivity.

bioRxiv · Dec 14, 2021Microbiology

Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice

K. Wu, A. Choi, M. Koch, S. Elbashir, L. Ma, D. Lee, A. Woods, C. Henry, C. Palandjian, A. Hill, H. Jani, J. Quinones, N. Nunna, S. O'Connell, A. B. McDermott, , D. K. Edwards

This study evaluates updated SARS-CoV-2 mRNA vaccines in mice, showing that mRNA-1273.351 boosts neutralization against B.1.351 and mRNA-1273.211 provides broad cross-variant protection.

bioRxiv · Apr 13, 2021Microbiology